3-[5-pyrazol-1-yl-3-[1-[(1-pyridin-2-ylpyrrolidin-3-yl)amino]-2,3-dihydro-1H-inden-5-yl]imidazo[4,5-b]pyridin-2-yl]pyridin-2-amine
C32H30N10 — CID 176699567
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[5-pyrazol-1-yl-3-[1-[(1-pyridin-2-ylpyrrolidin-3-yl)amino]-2,3-dihydro-1H-inden-5-yl]imidazo[4,5-b]pyridin-2-yl]pyridin-2-amine
3-[5-pyrazol-1-yl-3-[1-[(1-pyridin-2-ylpyrrolidin-3-yl)amino]-2,3-dihydro-1H-inden-5-yl]imidazo[4,5-b]pyridin-2-yl]pyridin-2-amine (PubChem CID 176699567) has the molecular formula C32H30N10 and a molecular weight of 554.66 g/mol. Its IUPAC name is 3-[5-pyrazol-1-yl-3-[1-[(1-pyridin-2-ylpyrrolidin-3-yl)amino]-2,3-dihydro-1H-inden-5-yl]imidazo[4,5-b]pyridin-2-yl]pyridin-2-amine.
Molecular Properties
| Compound Name | 3-[5-pyrazol-1-yl-3-[1-[(1-pyridin-2-ylpyrrolidin-3-yl)amino]-2,3-dihydro-1H-inden-5-yl]imidazo[4,5-b]pyridin-2-yl]pyridin-2-amine |
|---|---|
| PubChem CID | 176699567 |
| Molecular Formula | C32H30N10 |
| Molecular Weight | 554.66 g/mol |
| Exact Mass | 554.27 |
| IUPAC Name | 3-[5-pyrazol-1-yl-3-[1-[(1-pyridin-2-ylpyrrolidin-3-yl)amino]-2,3-dihydro-1H-inden-5-yl]imidazo[4,5-b]pyridin-2-yl]pyridin-2-amine |
| SMILES | Nc1ncccc1-c1nc2ccc(-n3cccn3)nc2n1-c1ccc2c(c1)CCC2NC1CCN(c2ccccn2)C1 |
| InChI | InChI=1S/C32H30N10/c33-30-25(5-3-15-35-30)31-38-27-11-12-29(41-17-4-16-36-41)39-32(27)42(31)23-8-9-24-21(19-23)7-10-26(24)37-22-13-18-40(20-22)28-6-1-2-14-34-28/h1-6,8-9,11-12,14-17,19,22,26,37H,7,10,13,18,20H2,(H2,33,35) |
| InChIKey | KYMUEMGRGPTFIQ-UHFFFAOYSA-N |
| XLogP | 4.50 |
| TPSA | 115.60 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 42 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 554.66 |
| LogP ≤ 5 | 4.50 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 176699567 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.